Lv2
127 积分 2021-06-27 加入
RAS(ON) Therapies on the Horizon to Address KRAS Resistance: Highlight on a Phase III Clinical Candidate Daraxonrasib (RMC-6236)
2天前
已完结
Frespaciguat ( MK-5475 ): A Novel Inhaled Soluble Guanylate Cyclase Stimulator for Pulmonary Hypertension Associated with COPD
20天前
已完结
Late-Stage Kinetic Hydrolysis to Prepare an Advanced Intermediate for Ibuzatrelvir
1个月前
已完结
Straightforward Synthesis of Halopyridine Aldehydes via Diaminomethylation
1个月前
已完结
Targeting focal adhesion kinase (FAK) in cancer therapy: A recent update on inhibitors and PROTAC degraders
1个月前
已完结
Targeting focal adhesion kinase: from molecular mechanisms to next-generation cancer therapeutics
1个月前
已完结
Identification of novel and potent PROTACs targeting FAK for non-small cell lung cancer: Design, synthesis, and biological study
1个月前
已完结
Development and Characterization of Selective FAK Inhibitors and PROTACs with In Vivo Activity
1个月前
已完结
Augmenting Protein Degradation Capacity of PROTAC through Energy Metabolism Regulation and Targeted Drug Delivery
1个月前
已完结
Degradation of FAK-targeting by proteolytic targeting chimera technology to inhibit the metastasis of hepatocellular carcinoma
1个月前
已完结
皖公网安备34019202002308
